Hybrid Gamma Camera in Breast Surgery
NCT02621099 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2017-05-05
Summary
A novel hand held hybrid optical-gamma camera (hereinafter referred to as the "camera") has been developed and can be used to image radiotracer distribution at the patient bedside. This study aims to evaluate the imaging capabilities of the camera in patients attending surgery for sentinel lymph node biopsy (SLNB) procedure. It is anticipated that this could improve the accuracy and simplify sentinel lymph node detection by providing fused optical and gamma imaging.
Conditions
Interventions
- DEVICE
-
Hybrid optical-gamma imaging
Acquisition of images using the camera as additional steps to the standard SLNB procedures.
Sponsors & Collaborators
-
Innovate UK
collaborator OTHER_GOV -
University of Nottingham
lead OTHER
Principal Investigators
-
Kwok Leung Cheung · University of Nottingham
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2017-02-28
- Completion
- 2017-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy
NCT02556684 ·Status: UNKNOWN
-
A Novel Optical Spectral Imaging System for Imaging Breast Tumor Margins
NCT01372631 ·Status: COMPLETED ·Phase: NA
-
Intraoperative Gamma Camera for Breast Cancer Surgery
NCT00757302 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Philips MicroDose Tomosynthesis System to 2D Digital Mammography
NCT02615509 ·Status: TERMINATED ·Phase: NA
-
Trop2-targeting NIR-II Molecular Probe for Breast Cancer Precise Surgery
NCT06713681 ·Status: COMPLETED
-
An Evaluation of a Self-contained Direct Digital Radiography System for Breast Specimen Imaging
NCT01379092 ·Status: UNKNOWN ·Phase: NA
-
Using Magnetic Resonance Spectroscopy With MRI to Non-invasively Determine Breast Cancer Extent of Disease
NCT00312637 ·Status: WITHDRAWN ·Phase: NA
-
Study of Preoperative Boost Radiotherapy
NCT02482389 ·Status: TERMINATED ·Phase: NA
-
Surveillance Imaging Modalities for Breast Cancer Assessment
NCT02212834 ·Status: COMPLETED
-
Optical Tomography With Ultrasound Guidance
NCT00908609 ·Status: COMPLETED
-
Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography
NCT01669148 ·Status: COMPLETED ·Phase: NA
-
Determination of Predictive Genetic Markers of Toxicity After Hypofractionated Radiotherapy in Breast Cancer Patients Post-Conservative Surgery
NCT01316328 ·Status: COMPLETED
-
Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer Study
NCT00282529 ·Status: TERMINATED ·Phase: NA
-
Computed Tomography (CT) Based Lymphatic Mapping and Localization of Sentinel Lymph Node in Breast Cancer Patients
NCT00952679 ·Status: UNKNOWN ·Phase: PHASE3
-
Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging
NCT01060085 ·Status: COMPLETED
-
Assessment of Lumpectomy Margins With the Histolog Scanner in Comparison With Intraoperative Imaging Techniques
NCT05118568 ·Status: COMPLETED
-
Near-Infrared Fluorescent Sentinel Lymph Node Mapping for Breast Cancer
NCT00721370 ·Status: COMPLETED ·Phase: PHASE1
-
The LightPath® and 68Ga-RM2 in Breast Cancer Study
NCT03731026 ·Status: UNKNOWN ·Phase: PHASE3
-
Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast Cancer
NCT03940092 ·Status: RECRUITING
-
The Added Value of DBT Over Mammography in Local Tumor Staging in Patients With BIRADS 4 or 5 Lesions
NCT06854887 ·Status: NOT_YET_RECRUITING
-
Intra-operative Detection of Positive Margins in Breast Surgery
NCT06977698 ·Status: RECRUITING
-
Fast Spectral Imaging Device for Tumor Margin Mapping
NCT01107080 ·Status: COMPLETED
-
Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant Treatment
NCT02891681 ·Status: COMPLETED ·Phase: NA
-
Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Known Breast Lesions
NCT01773850 ·Status: COMPLETED
-
The LightPath® Breast Cancer Study
NCT02666079 ·Status: UNKNOWN ·Phase: NA